Nanalysis Scientific Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Nanalysis Scientific.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Medical Equipment earnings growth | 17.1% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 29 Aug 2024 |
Recent future growth updates
Recent updates
Is Nanalysis Scientific (CVE:NSCI) Using Too Much Debt?
Oct 28
Nanalysis Scientific Corp.'s (CVE:NSCI) CEO Will Probably Find It Hard To See A Huge Raise This Year
Jun 19Nanalysis Scientific Corp. (CVE:NSCI) Stock Catapults 29% Though Its Price And Business Still Lag The Industry
May 12Benign Growth For Nanalysis Scientific Corp. (CVE:NSCI) Underpins Stock's 25% Plummet
Mar 24Nanalysis Scientific Corp. (CVE:NSCI) Shares Fly 43% But Investors Aren't Buying For Growth
Feb 08We Think Nanalysis Scientific (CVE:NSCI) Has A Fair Chunk Of Debt
Jan 31Would Nanalysis Scientific (CVE:NSCI) Be Better Off With Less Debt?
Aug 26Nanalysis Scientific Corp.'s (CVE:NSCI) Price Is Right But Growth Is Lacking
Apr 17Is Nanalysis Scientific (CVE:NSCI) Using Too Much Debt?
Dec 08Is Nanalysis Scientific (CVE:NSCI) Weighed On By Its Debt Load?
Jul 15Health Check: How Prudently Does Nanalysis Scientific (CVE:NSCI) Use Debt?
Jan 24Is Nanalysis Scientific (CVE:NSCI) Using Debt Sensibly?
Mar 29Nanalysis Scientific (CVE:NSCI) Has Debt But No Earnings; Should You Worry?
Dec 14
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Nanalysis Scientific has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2024 | 42 | N/A | N/A | N/A | 1 |
| 6/30/2024 | 39 | -13 | -4 | -1 | N/A |
| 3/31/2024 | 35 | -15 | -10 | -6 | N/A |
| 12/31/2023 | 28 | -16 | -16 | -11 | N/A |
| 9/30/2023 | 26 | -17 | -18 | -14 | N/A |
| 6/30/2023 | 26 | -13 | -20 | -14 | N/A |
| 3/31/2023 | 24 | -12 | -21 | -14 | N/A |
| 12/31/2022 | 25 | -9 | -16 | -9 | N/A |
| 9/30/2022 | 23 | -7 | -12 | -5 | N/A |
| 6/30/2022 | 19 | -5 | -9 | -3 | N/A |
| 3/31/2022 | 18 | -3 | -5 | -1 | N/A |
| 12/31/2021 | 16 | -2 | -4 | -1 | N/A |
| 9/30/2021 | 14 | -2 | -3 | -1 | N/A |
| 6/30/2021 | 12 | -2 | -3 | 0 | N/A |
| 3/31/2021 | 10 | -3 | -3 | 0 | N/A |
| 12/31/2020 | 8 | -4 | -4 | -1 | N/A |
| 9/30/2020 | 7 | -2 | -2 | 2 | N/A |
| 6/30/2020 | 7 | -2 | -3 | 1 | N/A |
| 3/31/2020 | 8 | -2 | -3 | 1 | N/A |
| 12/31/2019 | 8 | -2 | -2 | 1 | N/A |
| 9/30/2019 | 9 | -1 | -4 | -1 | N/A |
| 6/30/2019 | 9 | -1 | -2 | 0 | N/A |
| 3/31/2019 | 9 | 0 | -2 | 0 | N/A |
| 12/31/2018 | 8 | 0 | -2 | 0 | N/A |
| 12/31/2017 | 8 | 1 | N/A | 1 | N/A |
| 12/31/2016 | 5 | 0 | N/A | 1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if NSCI's forecast earnings growth is above the savings rate (2.3%).
Earnings vs Market: Insufficient data to determine if NSCI's earnings are forecast to grow faster than the Canadian market
High Growth Earnings: Insufficient data to determine if NSCI's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if NSCI's revenue is forecast to grow faster than the Canadian market.
High Growth Revenue: Insufficient data to determine if NSCI's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if NSCI's Return on Equity is forecast to be high in 3 years time